Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER ™ (Metformin Hydrochloride for Extended-Release Oral Suspension) Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit

Sun Pharmaceutical Industries, Inc. (SUN PHARMA), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. is voluntarily recalling one lot of RIOMET ER ™ (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL to the consumer level. The reason for the recall is due to

Source: FDA Center for Drug Evaluation and Research - What's New - September 23, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news